Antiretroviral therapy: coping with failure, planning for success.
Gallant
J E
JE
Johns Hopkins University, School of Medicine, Baltimore, MD.
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003657:Decision Making; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D017211:Treatment Failure; D017735:Virus Latency; D014779:Virus Replication / Q000187:drug effects
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors